Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.
Arzeda has raised $38.0M in total funding. The most recent round was Series C. The last funding was announced in September 2024.
Arzeda's investors include National Science Foundation, Sofinnova Partners, Casdin Capital, Circulate Capital, Lewis & Clark AgriFood.
Arzeda is headquartered in Seattle, United States.
Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.
Arzeda is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arzeda — Funding & Investors." VCBacked, September 17, 2024, https://www.vcbacked.co/company/arzeda. Accessed July 24, 2026.
VCBacked. (2024). Arzeda — Funding & Investors. Retrieved July 24, 2026, from https://www.vcbacked.co/company/arzeda
{{cite web |title=Arzeda — Funding & Investors |url=https://www.vcbacked.co/company/arzeda |website=VCBacked |access-date=July 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated